PP
TMCI icon

PDT Partners’s Treace Medical Concepts TMCI Stock Holding History

PDT Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-84,499
Closed -$709K – 842
2025
Q1 		$709K Buy
84,499
+55,336
+190% +$497K 0.05% 460
2024
Q4 		$217K Sell
29,163
-34,786
-54% -$233K 0.02% 641
2024
Q3 		$371K Buy
63,949
+31,235
+95% +$201K 0.03% 568
2024
Q2 		$218K Buy
+32,714
New +$264K 0.02% 598
2023
Q3 		– Sell
-24,566
Closed -$628K – 682
2023
Q2 		$628K Sell
24,566
-14,563
-37% -$376K 0.09% 346
2023
Q1 		$986K Buy
39,129
+13,589
+53% +$319K 0.13% 264
2022
Q4 		$587K Buy
25,540
+7,700
+43% +$177K 0.1% 351
2022
Q3 		$394K Sell
17,840
-6,880
-28% -$133K 0.06% 500
2022
Q2 		$354K Buy
+24,720
New +$416K 0.03% 702
2022
Q1 		– Sell
-19,974
Closed -$372K – 1116
2021
Q4 		$372K Buy
+19,974
New +$412K 0.03% 620

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDT Partners's TMCI Position: Q2 2025 in Review

PDT Partners sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 84,499 shares — an estimated $709K sold.

PDT Partners first reported a position in TMCI in Q4 2021 and held it in 10 quarters. The position peaked at $986K in Q1 2023. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • PDT Partners reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • PDT Partners sold 84,499 Treace Medical Concepts shares in Q2 2025, an estimated $709K.
  • PDT Partners first reported a position in Treace Medical Concepts in Q4 2021 and held it in 10 quarters.
  • PDT Partners's Treace Medical Concepts position peaked at $986K in Q1 2023.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on PDT Partners's 13F filing for Q2 2025, filed 14 Aug 2025.